Susan L Mooberry Selected Research

N-Methyl-D-Aspartate Receptors (NMDA Receptors)

4/2006

Lophocladines, bioactive alkaloids from the red alga Lophocladia sp.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susan L Mooberry Research Topics

Disease

43	Neoplasms (Cancer) 01/2023 - 01/2002
12	Triple Negative Breast Neoplasms 12/2022 - 06/2015
10	Breast Neoplasms (Breast Cancer) 10/2021 - 03/2004
3	Prostatic Neoplasms (Prostate Cancer) 03/2016 - 04/2006
3	Melanoma (Melanoma, Malignant) 06/2014 - 09/2010
2	Bites and Stings (Sting) 12/2022 - 10/2021
2	Ewing Sarcoma (Sarcoma, Ewing) 12/2021 - 01/2020
2	Leukemia 05/2009 - 04/2006
1	Medulloblastoma 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Malaria 03/2016
1	Vascular Remodeling 06/2015
1	Carcinoma (Carcinomatosis) 09/2010
1	Neuroblastoma 04/2006
1	Colonic Neoplasms (Colon Cancer) 01/2006

Drug/Important Bio-Agent (IBA)

7	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 07/2006
7	TubulinIBA 01/2023 - 09/2005
5	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2023 - 02/2006
5	eribulin FDA Link 12/2022 - 06/2015
4	Colchicine FDA LinkGeneric 01/2023 - 09/2005
3	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 01/2016
3	Estrogens (Estrogen)FDA Link 11/2017 - 03/2004
2	Mitochondrial DNA (mtDNA)IBA 12/2022 - 10/2021
2	Transcription Factors (Transcription Factor)IBA 12/2022 - 10/2019
2	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 01/2016
2	Antimitotic AgentsIBA 10/2021 - 04/2013
2	Immune Checkpoint InhibitorsIBA 10/2021 - 06/2021
2	SaltsIBA 11/2018 - 07/2014
2	Progesterone Receptors (Progesterone Receptor)IBA 11/2017 - 01/2016
2	taccalonolide AJIBA 01/2017 - 11/2011
2	maximiscinIBA 01/2016 - 01/2014
2	Docetaxel (Taxotere)FDA Link 07/2014 - 03/2014
2	Chalcone (Benzalacetophenone)IBA 10/2011 - 01/2010
2	Boronic AcidsIBA 01/2010 - 09/2005
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2008 - 03/2004
1	pyrimidineIBA 01/2023
1	Interferon-betaIBA 12/2022
1	ADU-S100IBA 12/2022
1	CytokinesIBA 12/2022
1	RNA (Ribonucleic Acid)IBA 12/2022
1	alteichinIBA 12/2021
1	altertoxin IIBA 12/2021
1	altertoxin IIIBA 12/2021
1	Cytotoxins (Cytolysins)IBA 12/2021
1	InterferonsIBA 10/2021
1	YuanhuacinIBA 06/2021
1	TetraspaninsIBA 06/2021
1	QuinazolinesIBA 01/2021
1	benzofuranIBA 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	CardenolidesIBA 01/2020
1	ChromatinIBA 10/2019
1	Proteins (Proteins, Gene)FDA Link 10/2019
1	Small Interfering RNA (siRNA)IBA 10/2019
1	englerin AIBA 09/2019
1	Clerodane DiterpenesIBA 01/2019
1	Cadherins (E-Cadherin)IBA 01/2018
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2018
1	IndolesIBA 01/2017
1	trichodermamide BIBA 01/2017
1	trichodermamide AIBA 01/2017
1	LupanesIBA 03/2016
1	Antimalarials (Antimalarial Agents)IBA 03/2016
1	PyrimidinesIBA 01/2016
1	human ERBB2 proteinIBA 01/2016
1	deguelinIBA 01/2016
1	taxaneIBA 06/2015
1	halichondrin BIBA 06/2015
1	AnthracyclinesIBA 06/2015
1	Epoxy Compounds (Epoxides)IBA 07/2014
1	Sunitinib (Sutent)FDA Link 07/2014
1	heteroneminIBA 03/2014
1	12-oxoheteroneminIBA 03/2014
1	non-ribosomal peptide synthaseIBA 01/2014
1	shikimateIBA 01/2014
1	Polyketide SynthasesIBA 01/2014
1	taccabulin AIBA 10/2013
1	2,5-dichloro-4-bromophenol (B 2)IBA 03/2012
1	amyrisin AIBA 03/2012
1	KetonesIBA 10/2011
1	evelyninIBA 09/2010
1	Taxoids (Taxanes)IBA 05/2009
1	Vinca AlkaloidsIBA 05/2009
1	CurcuminIBA 07/2008
1	DepsipeptidesIBA 05/2008
1	3,5- dibromo- 4- (3,4- dimethoxyphenyl)- 1H- pyrrole- 2- carboxylic acid ethyl esterIBA 07/2007
1	AcidsIBA 04/2006
1	lophocladine BIBA 04/2006
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2006
1	delta Opioid Receptors (delta Opioid Receptor)IBA 04/2006
1	lophocladine AIBA 04/2006
1	aurilide BIBA 04/2006
1	CB694IBA 02/2006
1	swinholide IIBA 01/2006
1	hurghadolide AIBA 01/2006
1	kulokekahilide-2IBA 08/2004
1	antineoplaston A10 (A 10)IBA 08/2004

Therapy/Procedure

10	Therapeutics 12/2021 - 03/2014
1	Immunotherapy 12/2022